Natco Pharma [NATCOPHARM] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison
Natco Pharma
NSE
Loading...
Sun Pharmaceutical
NSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Natco Pharma wins in 15 metrics, Sun Pharmaceutical wins in 5 metrics, with 0 ties. Natco Pharma appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Natco Pharma | Sun Pharmaceutical | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 8.62 | 36.63 | Natco Pharma |
| Price-to-Book Ratio | 2.14 | 5.27 | Natco Pharma |
| Debt-to-Equity Ratio | 3.67 | 3.26 | Sun Pharmaceutical |
| PEG Ratio | 22.00 | 48.56 | Natco Pharma |
| EV/EBITDA | 6.21 | 23.29 | Natco Pharma |
| Profit Margin (TTM) | 42.57% | 19.29% | Natco Pharma |
| Operating Margin (TTM) | 36.84% | 24.34% | Natco Pharma |
| EBITDA Margin (TTM) | 36.84% | 24.34% | Natco Pharma |
| Return on Equity | 27.97% | 15.08% | Natco Pharma |
| Return on Assets (TTM) | 15.78% | 11.87% | Natco Pharma |
| Free Cash Flow (TTM) | $11.85B | $119.44B | Sun Pharmaceutical |
| Dividend Yield | 0.68% | 1.26% | Sun Pharmaceutical |
| 1-Year Return | -36.97% | -8.55% | Sun Pharmaceutical |
| Price-to-Sales Ratio (TTM) | 3.67 | 7.13 | Natco Pharma |
| Enterprise Value | $136.28B | $3,572.58B | Sun Pharmaceutical |
| EV/Revenue Ratio | 3.08 | 6.64 | Natco Pharma |
| Gross Profit Margin (TTM) | 79.59% | 79.58% | Natco Pharma |
| Revenue per Share (TTM) | $247 | $224 | Natco Pharma |
| Earnings per Share (Diluted) | $105.30 | $43.32 | Natco Pharma |
| Beta (Stock Volatility) | 0.19 | 0.31 | Natco Pharma |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Natco Pharma vs Sun Pharmaceutical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Natco Pharma | -3.94% | -2.50% | -7.83% | 13.12% | -29.19% | -35.03% |
| Sun Pharmaceutical | -0.72% | -2.63% | -5.12% | -10.20% | -8.38% | -16.03% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Natco Pharma | -36.97% | 40.23% | 9.43% | 95.78% | 2,249.99% | 3,682.50% |
| Sun Pharmaceutical | -8.55% | 73.73% | 198.65% | 76.77% | 806.33% | 2,657.91% |
Performance & Financial Health Analysis: Natco Pharma vs Sun Pharmaceutical
| Metric | NATCOPHARM | SUNPHARMA |
|---|---|---|
| Market Information | ||
| Market Cap | ₹162.72B | ₹3.84T |
| Market Cap Category | Mid cap | Large cap |
| 10 Day Avg. Volume | 606,673 | 2,880,842 |
| 90 Day Avg. Volume | 1,444,085 | 2,133,319 |
| Last Close | ₹907.80 | ₹1,586.90 |
| 52 Week Range | ₹726.80 - ₹1,639.00 | ₹1,553.05 - ₹1,960.35 |
| % from 52W High | -44.61% | -19.05% |
| All-Time High | ₹1,639.00 (Sep 09, 2024) | ₹1,960.35 (Sep 30, 2024) |
| % from All-Time High | -44.61% | -19.05% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.14% | 0.10% |
| Quarterly Earnings Growth | 0.05% | -0.20% |
| Financial Health | ||
| Profit Margin (TTM) | 0.43% | 0.19% |
| Operating Margin (TTM) | 0.37% | 0.24% |
| Return on Equity (TTM) | 0.28% | 0.15% |
| Debt to Equity (MRQ) | 3.67 | 3.26 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹424.69 | ₹300.99 |
| Cash per Share (MRQ) | ₹162.87 | ₹108.88 |
| Operating Cash Flow (TTM) | ₹16.97B | ₹110.84B |
| Levered Free Cash Flow (TTM) | ₹8.90B | ₹109.29B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.68% | 1.26% |
| Last 12-Month Dividend | ₹6.00 | ₹21.00 |
Valuation & Enterprise Metrics Analysis: Natco Pharma vs Sun Pharmaceutical
| Metric | NATCOPHARM | SUNPHARMA |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 8.62 | 36.63 |
| Forward P/E | 22.00 | 48.56 |
| PEG Ratio | 22.00 | 48.56 |
| Price to Sales (TTM) | 3.67 | 7.13 |
| Price to Book (MRQ) | 2.14 | 5.27 |
| Market Capitalization | ||
| Market Capitalization | ₹162.72B | ₹3.84T |
| Enterprise Value | ₹136.28B | ₹3.57T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 3.08 | 6.64 |
| Enterprise to EBITDA | 6.21 | 23.29 |
| Risk & Other Metrics | ||
| Beta | 0.19 | 0.31 |
| Book Value per Share (MRQ) | ₹424.69 | ₹300.99 |
Financial Statements Comparison: Natco Pharma vs Sun Pharmaceutical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | NATCOPHARM | SUNPHARMA |
|---|---|---|
| Revenue/Sales | ₹12.21B | ₹137.86B |
| Cost of Goods Sold | ₹2.49B | ₹28.15B |
| Gross Profit | ₹9.72B | ₹109.71B |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | ₹4.50B | ₹33.72B |
| EBITDA | ₹6.14B | ₹47.66B |
| Pre-Tax Income | ₹5.06B | ₹31.73B |
| Income Tax | ₹999.00M | ₹8.70B |
| Net Income (Profit) | ₹4.06B | ₹22.93B |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | NATCOPHARM | SUNPHARMA |
|---|---|---|
| Cash & Equivalents | ₹1.20B | ₹102.69B |
| Total Current Assets | ₹52.70B | ₹526.24B |
| Total Current Liabilities | ₹9.44B | ₹181.94B |
| Long-Term Debt | ₹46.00M | ₹3.58B |
| Total Shareholders Equity | ₹76.12B | ₹724.86B |
| Retained Earnings | N/A | ₹578.62B |
| Property, Plant & Equipment | ₹24.32B | ₹100.36B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | NATCOPHARM | SUNPHARMA |
|---|---|---|
| Operating Cash Flow | N/A | N/A |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | N/A |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | NATCOPHARM | SUNPHARMA |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 606,673 | 2,880,842 |
| Average Daily Volume (90 Day) | 1,444,085 | 2,133,319 |
| Shares Outstanding | 179.11M | 2.40B |
| Float Shares | 81.34M | 1.04B |
| % Held by Insiders | 0.51% | 0.56% |
| % Held by Institutions | 0.13% | 0.25% |
Dividend Analysis & Yield Comparison: Natco Pharma vs Sun Pharmaceutical
| Metric | NATCOPHARM | SUNPHARMA |
|---|---|---|
| Last 12-Month Dividend | ₹6.00 | ₹21.00 |
| Last 12-Month Dividend Yield | 0.68% | 1.26% |
| 3-Year Avg Annual Dividend | ₹7.00 | ₹14.67 |
| 3-Year Avg Dividend Yield | 0.28% | 0.46% |
| 3-Year Total Dividends | ₹21.00 | ₹44.00 |
| Ex-Dividend Date | Feb 18, 2025 | Jul 07, 2025 |